Li et al. have reported that hsa-miR-34a-5p is downregulated in human GBM tissues, and this miR inhibits the cell cycle progression, cell viability, proliferation, and invasion of GBM in-vitro and in-vivo via targeting c-MET in GBM cells (Li et al., 2009[24]). This evidence concerns the gene MET and glioblastoma.